Platelet-rich plasma for stubborn corneal surface wounds
Part of Eyes & vision clinical trials.
This trial studies injecting your own platelet-rich plasma into the eye to help a persistent corneal surface defect heal. It may help if you have a recurring or nerve-related corneal ulcer, but it’s not for certain ulcer types or active eye infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a persistent (not healing) corneal surface defect.
- You have at least one qualifying problem: recurrent corneal epithelial defects, neurotrophic corneal ulcers, or nerve-related corneal damage from another condition (like diabetes, herpes infections, nerve problems, burns, injury, surgery, chronic dry eye, or some nerve diseases).
- Your ulcer is not a peripheral ulcerative keratitis or Mooren’s ulcer.
- You do not currently have an active infectious keratitis (an active eye infection) or an active infected ulcer.
- You must be available for the trial’s treatment and follow-up visits as required by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether your own platelet-rich plasma can help heal a fragile, slow-to-recover cornea caused by reduced corneal feeling (nerve damage). It may help reduce corneal erosion and improve corneal surface healing.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests whether an injection of a special concentrate from your own blood (platelet-rich plasma, or PRP) can help calm severe dry eye disease. It’s meant for people whose dry eye has not improved with other treatments.
This trial tests whether a treatment made from your own blood (platelet-rich plasma) can help heal deep skin ulcers (Grade III) that have been present for more than two weeks. It may be a good option if you have a normal platelet count and are not in palliative care.
This study tests whether a treatment made from your own blood (platelet-rich plasma or platelet-rich fibrin) can help heal chronic skin ulcers better than standard care. If you have a non-healing ulcer that fits the size and duration criteria, and you are generally healthy, you may be able to participate.
This trial compares two treatments for persistent corneal surface wounds that haven't healed with standard care. You'll receive either insulin eye drops or a special tissue graft to help your cornea heal.
Hear when a new Persistent Epithelial Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.